COVID-19 vaccination programme
Per capita fully vaccination map as of 4 April 2023
Date16 January 2021 (2021-01-16) – present
(3 years, 0 days ago)
Location India
CauseCOVID-19 pandemic in India
TargetImmunisation of Indians against COVID-19
Budget₹35,000 crore (US$4.4 billion)[1]
Organised byGovernment of India
Indian Council of Medical Research
State governments of India
Participants
  • 1,025,789,302 people with one dose administered of Covaxin or Oxford–AstraZeneca vaccine or Sputnik V
  • 952,033,158 people have been fully vaccinated with both doses of Covaxin or Oxford–AstraZeneca vaccine or Sputnik V or Corbevax
  • 228,593,024 people have been administered Precautionary/Booster doses of Covaxin or Oxford–AstraZeneca vaccine or Sputnik V or Corbevax
Outcome
  • 74% of the Indian population has received one dose.
  • 69% of the Indian population has received both doses
WebsiteMoHFW
As on 4th March 2023 (07:00AM)

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines.[2][3] In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.[4][5]

India initially approved the Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name Covishield) and Covaxin (a vaccine developed locally by Bharat Biotech). They have since been joined by the Sputnik V (manufactured under license by Dr. Reddy's Laboratories, with additional production from Serum Institute of India being started in September[6][7]), Moderna vaccines, Johnson & Johnson vaccine and ZyCoV-D (a vaccine locally developed by Zydus Cadila)[lower-alpha 1][lower-alpha 2] and other vaccine candidates undergoing local clinical trials.

According to a June 2022 study published in The Lancet, COVID-19 vaccination in India prevented an additional 4.2 million deaths from December 8, 2020, to December 8, 2021.[8][9]

Vaccination programme

Cumulative doses administered across the country

Total doses administered across the country as of March 4, 2023 [10][5]

Dose Vaccination (Percentage of eligible population vaccinated)
Partially Vaccinated
1,025,789,302(94.61)
Fully Vaccinated
952,033,158(87.81)
Precautionary(Booster) Dose
228,593,024

Monthly graph of cumulative doses administered across the country

Graph of daily doses administered across the country

Graph of daily doses administered. Last updated: March 4, 2023[11]

   Daily vaccinations (1st dose only)    Daily vaccinations (2nd dose only)

Vaccine administration by Gender

Vaccinations in India by Gender as of March 4, 2023[10][5]

Gender Vaccination
Male 1,00,60,86,799
Female 96,74,31,679
Others 4,80,887

Vaccine administration by vaccine brand

Vaccinations in India by Vaccine Brand as of March 4, 2023 [10][5]

Brand Vaccination
Covishield 1,74,93,57,213
Covaxin 36,37,74,435
Sputnik V 12,32,692
Corbevax 7,38,04,121
Covovax 33,326

Vaccine administration by age group

Vaccinations in India by Age Group as of March 4, 2023 [10][5]

Age Group Vaccination
12-14 7,38,25,081
15-17 11,59,42,821
18-44 1,13,08,38,083
45-60 41,97,83,374
60+ 30,23,46,969

States by Vaccine Coverage

(as of 15 September (7:00 IST))

Number of Vaccination Centres

Sites conducting vaccination in India

Total-1,12,700
• Government[fn 1] — 1,10,000
• Private[fn 2] — 2,700

Source: CoWin Dashboard[12]

Citizens above the age of 12 can book appointments through the COWIN platform or can do a Walk-In registration on site. All vaccine centres have registration desks, vaccine booths and observation rooms. Vaccine certificates can be downloaded digitally through the COWIN platform, or citizens can ask for a hard copy from vaccination centres. All government run vaccination centers provide free of cost vaccines, private centers do charge.[13]

Background and timeline

A vaccination centre in Delhi.
India's COVID-19 vaccination deployment until 3 June

First Phase, initial approvals, launch of vaccination programme

In September 2020, India's Health minister Harsh Vardhan stated that the country planned to approve and begin distribution of a vaccine by the first quarter of 2021.[14] The first recipients were to be 30 million health workers directly dealing with COVID patients.[15]

A vial of Covishield, the Indian-manufactured version of the AstraZeneca vaccine.
A vial of Covaxin
Vaccination drive for COVID prevention in Bhopal, India

On 1 January 2021, the Drug Controller General of India (DCGI) approved emergency use of the Oxford–AstraZeneca vaccine (local trade name "Covishield").[16][17][18] On 2 January, the DCGI also granted an interim emergency use authorisation to BBV152 (trade name "Covaxin"), a domestic vaccine developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology.[19] This approval was met with some concern, as the vaccine had not then completed phase 3 clinical trials.[20] Due to this status, those receiving Covaxin were required to sign a consent form,[21] while some states chose to relegate Covaxin to a "buffer stock" and primarily distribute Covishield.[22]

COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021

India began its vaccination programme on 16 January 2021, operating 3,006 vaccination centres on the onset.[23] Each vaccination centre will offer either Covishield or Covaxin, but not both.[24] 165,714 people were vaccinated on the first day of availability. Difficulties in uploading beneficiary lists at some sites caused delays.[25] In the first three days, 631,417 people were vaccinated. Of these, 0.18% reported side-effects and nine people (0.002%) were admitted to hospitals for observation and treatment.[26][27] Within those first days, there were concerns about low turnout, due to a combination of vaccine safety concerns, technical problems with the software used, and misinformation.[28]

The first phase of the rollout involved health workers and frontline workers, including police, paramilitary forces, sanitation workers, and disaster management volunteers.[23] By 1 March, only 14 million healthcare and frontline workers had been vaccinated, falling short of the original goal of 30 million.[29]

Second phase

The next phase of the vaccine rollout covered all residents over the age of 60, residents between the ages of 45 and 60 with one or more qualifying comorbidities, and any health care or frontline worker that did not receive a dose during phase 1. Online registration began on 1 March via the Aarogya Setu app and Co-WIN ("Winning over COVID-19") website.[30][31][32] Amid the beginnings of a major second wave of infections in the country,[33][34][35] vaccine exports were suspended in March 2021, and the government ordered 110 million Covishield doses from SII.[36] The company aims to produce 100 million doses per month, but by May 2021 its production capacity was only 60–70 million doses.[37][38] Following the conclusion of its trial, the DCGI issued a standard emergency use authorisation to Covaxin on 11 March 2021.[39]

From 1 April, eligibility was extended to all residents over the age of 45.[40] On 8 April, Prime Minister Narendra Modi called for a four-day Teeka Utsav ("Vaccine Festival") from 11 to 14 April, with a goal to increase the pace of the program by vaccinating as many eligible residents as possible. By the end of the Utsav, India had reached a total of over 111 million vaccine doses to-date.[41][42][43]

Third phase, Sputnik V approval

On 12 April, the DCGI approved Russia's Sputnik V vaccine for emergency use in India. A phase 3 trial was conducted in the country in September 2020, which showed 91.6% efficacy.[44] The local distributor Dr. Reddy's Laboratories stated that it planned to have the vaccine in India by late May 2021.[45]

On 19 April, it was announced that the next phase of the vaccination programme would begin on 1 May, extending eligibility to all residents over the age of 18. Under phase 3, individual stakeholders were also given more flexibility in how they conduct the vaccination programme. As part of this plan, only half of the vaccines procured by the Central Drugs Laboratory from manufacturers would be distributed by the central government. This supply would go to government-run clinics and be offered free-of-charge to residents 45 and over and priority workers and siphoned off to states based on factors such as the number of active cases and how quickly they are administering vaccines. The remainder would be offered to individual states and purchased on the open market (including private hospitals), which would be able to serve residents over the age of 18.[46][47][48]

Registration for the next phase began on 28 April; a single-day record of nearly 13.3 million people registered.[49] Due to supply issues, several states, including Delhi, Gujarat and Madhya Pradesh announced that they would delay their wider rollouts of vaccines to later in the month.[50]

The initial shipment of 150,000 Sputnik V doses arrived on 1 May, and began to be administered on 14 May.[51][52][53] An estimated 156 million doses is expected between August and December; initially, doses will be sourced from Russia, but domestic production is expected to begin by August 2021.[54][55][56]

On 13 May, the DCGI approved phase 2 and phase 3 trials of Covaxin on children 2–18.[57] On 14 May, health officials projected that based on the anticipated approval of additional vaccine options, it could receive at least 2.17 billion more vaccine doses from August to December 2021.[58][59] On 25 May, India exceeded 200 million vaccine doses administered in total.[60] On 3 June, the Ministry of Health and Family Welfare pre-ordered 300 million doses of a potential fourth vaccine, Corbevax, which is undergoing phase 3 clinical trials.[61]

On 23 May, the union government allowed walk-in registrations for vaccination throughout the country; a health worker at the vaccination centre would register the recipient in the Co-win vaccination database. The government claimed in an affidavit to the Supreme Court that as of June 23 about 78 per cent of vaccines had been administered via walk-in registration.[62]

Return to centralised procurement

On 31 May, an affidavit was issued in the Supreme Court of India requesting a review of the central government's vaccine distribution strategy, suggesting that the decision to only offer doses at no charge to priority workers and residents over the age of 45 was "prima facie arbitrary and irrational".[63]

On 7 June, Prime Minister Modi announced that India would migrate back to centralised procurement of vaccines by 21 June. In an address, Modi stated that multiple chief ministers had requested that the central government reconsider its new distribution strategy and reinstate the system it had used before May. As before, the centre will procure up to 75% of the country's vaccine supplies from manufacturers in bulk and distribute them to states at no additional charge. Vaccines would now be offered at no charge for those in the 18–44 age group. Private hospitals will still be responsible for the remaining 25% of procurement, but fees for appointments are now capped at ₹150 (US$1.90).[64][65]

On 21 June, the day these changes took effect, approximately 8,270,000 doses were administered—India's largest single-day total until that point. The states of Madhya Pradesh and Karnataka had the highest local totals.[66][67][68] Member of Parliament, Rajya Sabha P. Chidambaram accused Bharatiya Janata Party of having "hoarded" vaccine doses in the days leading up to 21 June in order to encourage larger numbers; seven states controlled by the BJP were among the top ten states to have administered vaccine doses that day, few of these states had below-average vaccination numbers in the days leading up to 21 June (such as Madhya Pradesh, which went from 692 doses on 20 June to 1,690,000 the next day, and numbers had dropped significantly in the state the next day).[69][70][71][72]

On 23 June, India surpassed over 300 million vaccine doses administered in total.[73] On 28 June, India overtook the United States in total vaccine doses administered.[74] On 29 June, the DCGI approved the Moderna vaccine (which is being imported by Cipla) for emergency use. Vinod Kumar Paul stated that the Pfizer vaccine was also likely to be approved soon.[75][76]

500 million mark, Johnson & Johnson Covid-19 vaccine approval and record

On 6 August 2021, India crossed the 500 million doses milestone within 6 months from the onset of the vaccination program.[77]

On 7 August 2021, the Drug Controller General of India (DCGI) approved emergency use of the Johnson and Johnson single-dose vaccine.[78] On 16 Aug 2021, India administered around 8.81 million doses of COVID-19 vaccines, achieving the highest single-day record and overtaking its own previous record of 8.61 million doses, by 16 August the cumulative doses had surpassed the 550 million mark.[79][80]

ZyCoV-D approval for ages 12 & above and single day vaccination records

On 20 August 2021, India granted emergency authorization to Zydus Cadila's vaccine ZyCoV-D, the world's first DNA plasmid-based COVID-19 vaccine, for patients 12 and older.

India granted emergency use approval to the world's first DNA based COVID-19 vaccine, manufactured by for adults and children aged 12 years and above. The vaccine is administered using a needle-free applicator.[81][82] The government announced on 30 September 2021 that the ZyCoV-D vaccine will be a three dose vaccine and it will be included in the Covid vaccination programme of India.[83]

Since August 10, 2021, foreign nationals residing in India can now receive the COVID-19 vaccine by registering themselves on the Cowin platform; like other eligible beneficiaries, the foreign nationals can book a slot via the portal and use their passport as a document to verify their identity for the registration process.[84]

By 26 August 2021, 50% of the adult population in India were inoculated with at least one dose of the approved vaccines, which included 99% coverage among healthcare workers and 100% front-line workers for the first dose.[85]

On 27 August 2021, India crossed the milestone of administering more than 10 million (1 crore) doses of COVID-19 vaccine in a single day, setting a new world record. Uttar Pradesh topped the list with 2.8 million doses, followed by Karnataka with 1 million doses and Maharashtra at third with 0.98 million doses.[86]

On 29 August 2021, Himachal Pradesh became the first state to complete administering first doses of COVID-19 vaccines to 100% of the population.[87] On 31 August, India again set another single-day vaccination record by inoculating around 12 million (1.2 Crore) doses in 24 hours.[88]

By September 2021, all adult people in Sikkim, Dadra and Nagar Haveli, Himachal Pradesh, Goa, Ladakh, and Lakshadweep have received at least one dose of Covid vaccine as the cumulative jabs administered in the country crossed 75 crores. Many city corporations, talukas, gram panchayats and districts had also administered the first dose of COVID-19 vaccination to 100 per cent of their adult population.[89][90] [91]

As many as 25 million people were vaccinated on Narendra Modi's birthday on 17 September 2021. This is the highest single-day vaccination tally so far in the whole world.[92] There are allegations that a lot of pressure could have been put on officials to increase and twist to record vaccination numbers on the Prime Minister's birthday as some people who had not received their Covid shots somehow seem to have been issued vaccination certificates including those who are deceased.[93][94]

On 27 September, India administered over 1 crore vaccine doses for the fifth time, and total vaccination coverage crossed 86 crore (860 million).[95] On 2 October, this increased to 960 million.[96]

Booster doses and pediatric vaccines

By September 2021, several companies had received approval to begin clinical trials on COVID-19 vaccines for children.[97] Discussions were also emerging over whether India would utilize vaccine booster doses, with the government having maintained that they were studying their applicability, and that they were focused on their goal to administer a primary series of vaccine doses to all adults.[98] On 21 October 2021, India crossed the one billion mark for administered doses.[99]

On 26 December 2021, Prime Minister Modi announced that vaccine eligibility would be extended to youth 15 to 18 years of age from 3 January 2022 (with online registration opened on 1 January 2022); this age group would exclusively receive Covaxin. It was also announced that booster doses would become available from 10 January 2022, beginning with frontline workers, and residents over the age of 60 with comorbidities. Within this cohort, doses would be prioritized to those who had received their second dose at least nine months prior.[100][101]

On 14 March 2022, Union health minister Mansukh Mandaviya announced that vaccine eligibility would be extended to children 12–14, and that this group would exclusively receive Corbevax. Booster eligibility was also extended to all adults 60 and older.[102] On 8 April 2022, the Ministry of Health and Family Welfare announced that all adults 18 and over would become eligible for booster doses beginning 10 April, and that they would be available via private vaccination centres.[103]

In May 2022, the Supreme Court of India ruled that COVID-19 vaccine mandates were unconstitutional, citing the "emerging scientific opinion" that COVID-19 vaccines did not reduce the risk of transmission by those who are vaccinated.[104]

Vaccine development and distribution

Prime Minister Narendra Modi visiting the Serum Institute of India on 28 November 2020.

As of early May 2020, there were over 30 vaccine candidates in development in India, many of which were already in pre-clinical trials.[105]

The Pune-based Serum Institute of India (SII) is the world's largest vaccine maker. This existing capacity enabled India to be a major participant in the COVAX programme to distribute vaccines to developing countries.[106] In February 2020, SII had begun animal trials of vaccine candidates.[107] SII announced in April 2020 that it would apply for clinical trials from the Drug Controller General of India (DCGI) in April 2020. SII president Adar Poonawalla said that a vaccine would be delivered within a year, but projected an efficacy between 70 and 80%.[108]

In August 2020, SII received approvals for phase 2 and phase 3 trials of its version of a vaccine being developed by AstraZeneca and the University of Oxford's Vaccitech.[109] SII joined GAVI in a partnership with the Bill & Melinda Gates Foundation to produce 100 million doses of vaccine for developing countries.[110] The SII planned to manufacture 1.5 and 2.5 billion doses of the AstraZeneca vaccine per-year under the trade name "Covishield".[111] By its approval in January 2021, the company had stockpiled 50 million doses, but well short of its own target of 400 million.[112][113] The government ordered 21 million doses to be delivered by February, but the company said no indication of any further orders were given.[36] The company began to export the remaining stocks instead.[111]

Hyderabad-based Bharat Biotech, in collaboration with U.S.-based FluGen, expected to begin the first clinical trials of a nasal vaccine by late-2020.[114] The Indian Council of Medical Research partnered with Bharat Biotech in May 2020 to develop a COVID vaccine entirely within India.[115] In June 2020, it received DCGI approval to begin phase 1 and phase 2 trials on its vaccine, BBV152 (trade name "Covaxin").[116] In September 2020, it was reported that in pre-clinical trials on animals, Covaxin was able to build immunity.[117] In July 2021, Bharat Biotech reported the vaccine to be 64% (95% CI, 29–82%) effective against asymptomatic cases, 78% (65–86%) effective against symptomatic cases, 93% (57–100%) effective against severe COVID-19 infection, and 65% (33–83%) effective against the Delta variant.[118][119] On 20 April 2021, Bharat Biotech announced that it had expanded its production capabilities for Covaxin to 700 million doses per-year.[120]

Cadila Healthcare began vaccine development in March 2020, including a viral vector vaccine and a DNA plasmid vaccine.[121][122] In mid-July 2020, Cadila held early human trials of its vaccine candidate ZyCoV-D,[123] and received approval for phase 3 trials in January 2021.[124][125] It began large-scale production in April 2021, with Cadila expecting to receive emergency authorisation between May and June 2021.[126] On 1 July 2021, Cadila Healthcare reported the efficacy to be 66.6% against symptomatic COVID-19 and 100% against moderate or severe disease in its interim analysis of its phase 3 trial data.[127][128]

In September 2020, Dr. Reddy's partnered with the Russian Direct Investment Fund (RDIF) to conduct phase 3 trials of the Sputnik V vaccine in India, and to distribute the vaccine there once approved.[129][130] In April 2021, RDIF CEO Kirill Dmitriev told NDTV that they had "five great manufacturers in India" who would be producing the vaccine, and felt that the country could become Sputnik V's "production hub" for use and export.[131] Dr. Reddy's is also working with the RDIF on approval of "Sputnik Light"—a regiment of Sputnik V consisting only of the first dose.[56]

In April 2021, phase 3 clinical trials were approved for another vaccine, Corbevax, a protein subunit that is being developed by BioE, the Baylor College of Medicine, and Dynavax Technologies.[61][132]

On 2 June 2021, the DCGI removed the requirement that India-specific clinical trials (bridging trials) be held for vaccine candidates developed outside of India, provided that they are already approved by a recognised international public health agency such as the World Health Organization (WHO), European Medicines Agency (EMA), US Food and Drug Administration (FDA), UK Medicines and Healthcare products Regulatory Agency (MHRA), or Japan's Pharmaceuticals and Medical Devices Agency. These changes were intended to help expedite the availability of vaccines already in use in other countries.[75][133]

In mid-July, it was reported that approval of the Moderna and Pfizer vaccines, as well as a shipment of vaccines donated by the United States (which includes the AstraZeneca, Janssen, Moderna, and Pfizer vaccines), had faced delays due to requests from their manufacturers for indemnity clauses from Indian authorities, which would relieve them from legal liability for adverse reactions.[134][135]

On 21 September 2021, the Indian Government said that it will not purchase the Pfizer-BioNTech and Moderna vaccines as domestic output of more affordable and easier-to-store vaccines has jumped.[136]

In the Quad summit, Prime Minister Narendra Modi announced that India would make 8 million doses of J&J vaccine available by the end of October under the Quad vaccine partnership. It will be manufactured in India by the Biological E. This would be ready by the end of October, compatible with our decision to resume vaccine export.[137]

On 6 February 2022, DCGI approved Sputnik Light Covid vaccine for emergency use in India.[138]

Vaccine deployment strategies

Optimizing vaccination deployment for India[139] includes tailoring of strategies to the demographic and epidemiologic situation by modeling vaccination scenarios,[140] explore measures to reach children at risk[141] and co-optimizing vaccination strategy for societal and individual benefit in parallel.[142]

Vaccine on order

Vaccine Status Production Capacity Planned Capacity Doses ordered Approval Deployment
Covishield In use 840 million [143] - 750 million [144][145] 01 January 2021[146] 16 January 2021[147]
Covaxin In use 700 million [148] - 550 million [144] 03 January 2021[149] 16 January 2021[147]
Sputnik V In use 140 million - 156 million [150][144] 12 April 2021[44] 14 May 2021[151]
Corbevax In use - 960 million [152] 300 million [153] 28 December 2021[154] 16 March 2022[155]
Moderna Approved Import only[156] - - 29 June 2021[157] Order Cancelled[158]
Johnson & Johnson Approved - 8 million[137] - 7 Aug 2021 [159] Not yet[137]
ZyCoV-D Approved - 240 million [160] 10 million[161] 20 August 2021[162] Not yet
Covovax Approved - - 200 million [144] 28 December 2021[154] Not yet
Sputnik Light Approved - - - 6 February 2022[138] Not yet

In September 2021, India's government announced that it would not buy COVID-19 shots from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O), mainly because the domestic output of more affordable and easier-to-store vaccines of Serum Institute of India, Bharat Biotech & Cadila Healthcare has jumped. India will make 8 million doses of the Johnson and Johnson vaccine available by the end of October under the Quad vaccine partnership.[137][155]

Vaccines in trial stage

Vaccine Type (technology) Phase I Phase II Phase III No. of Participants in Clinical Trial Planned Capacity
BBV154 Adenovirus vector (intranasal) Completed In progress Pending 175[163][164] 100 million[144]
HGC019 mRNA Completed In progress Pending 120 [165] 60 million [144]

Global distribution of India-manufactured vaccines

Vaccine Maitri (English: Vaccine Friendship)[166] is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world.[167] The government started providing vaccines from 20 January 2021. As of 6 March 2022, India had delivered around 16.3 cror doses of vaccines to 96 countries.[168] Of these, 1.43 cror doses were gifted to 46 countries by the Government of India. The remaining 10.71 cror were supplied by the vaccine producer under its commercial and, 4.15 cror doses were supplied throw COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines.[169] The Health Minister of India, Mr. Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.[170][171]

Countries that received doses of the Indian-made Covaxin as of 6 March 2021

200,000 doses of COVID-19 vaccines were gifted by India to the UN peacekeepers on 27 March to be distributed to all peacekeeping missions.[172]

Vaccines

India has two approved COVID-19 vaccines: Covishield and Covaxin. Both of them were exported and used in foreign grants by the Government of India.

Covishield

A vial of Covishield, the Indian-manufactured version of the AstraZeneca vaccine.

On 1 January 2021, the Drug Controller General of India, approved the emergency or conditional use of Covishield.[173] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[174]

Covaxin

A vial of Covaxin, India's first indigenous COVID-19 vaccine by Bharat Biotech

On 2 January 2021, Covaxin India's first COVID-19 vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[175]

Vaccine supply

India kicked off international shipment of the vaccines on 20 January 2021, only four days after starting its own vaccination program.[176] Bhutan and Maldives were the first countries to receive vaccines as a grant by India. This was quickly followed by shipments to Nepal, Bangladesh, Myanmar and Seychelles.[176] By mid-March 2021, India was also supplying vaccines on a commercial basis to countries including Canada,[177] the UK,[178] and Saudi Arabia.[179]

As of 21 February 2022, India had exported total 16,29,63,500 doses including 1,42,67,000 vaccine provided as grant to more than 96 nations and, UN Peacekeepers and UN Health workers.[168]

The Serum Institute of India was selected as a key supplier of cost-effective COVID-19 vaccines to the COVAX initiative,[180] 19.8 million doses of Covishield vaccines were supplied by India to various countries through the initiative.[168] In May, when COVAX was already short 140 million doses,[181] the Serum Institute announced that it expected to maintain its suspension of vaccine deliveries to COVAX through the end of 2021[182] due to the second wave of COVID-19 in India[183] and the US ban on export of key raw materials.[184]

International reaction

International organizations

  • IMF: IMF chief economist Gita Gopinath lauded India for playing a key role during the crisis by dispatching vaccines to many countries. She said "I also want to mention that India really stands out in terms of its vaccine policy. If you look at where exactly is one manufacturing hub for vaccines in the world – that will be India."[185]

Countries

  •  Jamaica[186] of the OACPS has thanked Indian efforts in delivering vaccines to developing and least developed countries.
  •    Nepal Prime minister Khadga Prasad Oli thanked India stating; "We got an early chance to administer the Covid-19 vaccine. For this, I thank our neighbouring nation India, its government, the people, and especially Prime Minister Narendra Modi. They sent 10 lakh doses of vaccines to us as a grant within a week of the roll-out in India."[187]
  •  St. Lucia on behalf of CARICOM thanked India for providing vaccine supplies to them.[186][188]
  •  Barbados Prime Minister Mia Amor Mottley thanked Prime Minister Narendra Modi for the supply of "Made in India" COVID-19 vaccines. She tweeted, "PM Modi made it possible for more than 40,000 persons in Barbados and tens of thousands elsewhere, to receive their 1st dose of COVISHIELD via Vaccine Maitri before receiving his. A genuine demonstration of generosity. Thank you and we wish you continued good health."[189]
  •  Antigua and Barbuda Prime Minister Gaston Browne had thanked Prime Minister of India Narendra Modi "for demonstrating an act of benevolence, kindness and empathy", for sending vaccines to Caribbean countries.[190]
  •  Afghanistan Afghanistan's ambassador to India Farid Mamundzay said "Thank you, India for providing Afghan people lifesaving gift on the first day of 2022!"[191]

Leaders who received vaccines provided by India

Vaccination rollout statistics by State or UT

State/union territory Population (2021 census projection) 1st dose 2nd dose Precautionary/ Booster Dose Cumulative doses administered Percentage of people given one dose Percentage of people fully vaccinated
India 1,38,94,19,783 1,02,57,89,302 95,20,33,158 22,85,93,024 2,20,64,15,484 74% 69%
Andaman and Nicobar Islands 4,00,000 3,47,616 3,53,284 2,90,363 9,91,263 87% 88%
Andhra Pradesh 5,27,87,000 4,47,04,006 4,75,78,542 1,86,73,709 11,09,56,257 85% 90%
Arunachal Pradesh 15,33,000 9,61,347 8,21,814 1,41,357 19,24,518 63% 54%
Assam 3,50,43,000 2,48,12,811 2,21,46,472 33,70,486 5,03,29,769 71% 63%
Bihar 12,30,83,000 7,34,81,173 6,79,02,890 1,58,80,011 15,72,64,074 60% 55%
Chandigarh 12,08,000 11,85,483 9,88,149 1,13,952 22,87,584 98% 82%
Chhattisgarh 2,94,93,000 2,12,67,642 2,03,43,637 75,56,167 4,91,67,446 72% 69%
Dadra and Nagar Haveli 6,08,000 4,62,349 3,56,857 80,437 8,99,643 76% 59%
Daman and Diu 4,09,000 3,19,979 2,80,074 79,977 6,80,030 78% 68%
Delhi 2,05,71,000 1,82,95,806 1,57,15,408 33,90,516 3,74,01,730 89% 76%
Goa 15,59,000 14,40,021 12,95,703 1,38,544 28,74,268 92% 83%
Gujarat 6,97,88,000 5,43,96,424 5,40,29,392 1,96,58,376 12,80,84,192 78% 77%
Haryana 2,94,83,000 2,36,78,004 1,98,37,948 19,93,858 4,55,09,810 80% 67%
Himachal Pradesh 73,94,000 66,46,431 63,27,364 23,48,606 1,53,22,401 90% 86%
Jammu and Kashmir 1,34,08,000 1,13,72,533 1,17,68,086 16,41,339 2,47,81,958 85% 88%
Jharkhand 3,84,71,000 2,39,67,125 1,78,51,928 20,38,403 4,38,57,456 62% 46%
Karnataka 6,68,45,000 5,51,73,853 5,53,90,664 1,15,80,517 12,21,45,034 83% 83%
Kerala 3,54,89,000 2,91,49,999 2,52,69,114 30,83,315 5,75,02,428 82% 71%
Ladakh 2,97,000 2,38,303 2,04,097 1,24,714 5,67,114 80% 69%
Lakshadweep 68,000 61,813 60,521 22,926 1,45,260 91% 89%
Madhya Pradesh 8,45,16,000 6,07,49,230 5,92,31,988 1,39,55,836 13,39,37,054 72% 70%
Maharashtra 12,44,37,000 9,16,68,492 7,66,19,826 96,49,039 17,79,37,357 74% 62%
Manipur 31,65,000 16,49,406 13,39,146 2,80,404 32,68,956 52% 42%
Meghalaya 32,88,000 14,46,758 10,87,649 91,016 26,25,423 44% 33%
Mizoram 12,16,000 8,94,318 7,50,177 1,48,803 17,93,298 74% 62%
Nagaland 21,92,000 9,23,844 7,44,853 70,898 17,39,595 42% 34%
Odisha 4,56,96,000 3,52,50,660 3,30,11,967 1,32,82,350 8,15,44,977 77% 72%
Puducherry 15,71,000 9,94,613 8,68,099 4,11,347 22,74,059 63% 55%
Punjab 3,03,39,000 2,41,61,300 2,09,93,294 18,88,564 4,70,43,158 80% 69%
Rajasthan 7,92,81,000 5,70,33,302 5,10,28,962 76,28,646 11,56,90,910 72% 64%
Sikkim 6,77,000 5,91,875 5,54,656 2,13,916 13,60,447 87% 82%
Tamil Nadu 7,64,02,000 6,12,13,217 5,72,16,684 90,89,575 12,75,19,476 80% 75%
Telangana 3,77,25,000 3,24,46,658 3,15,58,188 1,35,45,844 7,75,50,690 86% 84%
Tripura 40,71,000 29,16,816 25,23,858 4,78,322 59,18,996 72% 62%
Uttar Pradesh 23,09,07,000 17,69,98,255 16,89,68,355 4,60,35,998 39,20,02,608 77% 73%
Uttarakhand 1,13,99,000 91,18,200 87,30,370 22,85,740 2,01,34,310 80% 77%
West Bengal 9,81,25,000 7,35,26,540 6,67,04,028 1,58,55,654 15,60,86,222 75% 68%
Miscellaneous — 22,43,100 15,79,114 14,73,499 52,95,713 — —
As of March 4, 2023 7:00 AM IST[194]

As of March 4, 2023, populations above the age of 12 are only eligible for vaccination. The percentage of population inoculated shown in the table above is according to the 2021 projected population of India with all age groups. According to the government, based on the projected mid-year count for 2021, the country's total population aged 12 years and above is approximately 108 crore. Around 94.61% of the 12+ population of the country have received at least one dose of the COVID-19 vaccine since the vaccination drive began. In addition to this, 87.81% of the eligible population has been fully vaccinated.[195]

Vaccine acceptance in India

Over 80% of the population of India have a positive response for getting anti covid shots. India has one of the lowest vaccine hesitancy in the world.[196] There was vaccine hesitancy in the initial months of 2021, especially in rural India and among poor and tribal populations. Constant government and public awareness drastically reduced vaccine hesitancy. Since May 2021, more than half of daily doses administered in India have been from rural parts.[197] Vaccine centers in India have witnessed large number of people willing to get covid vaccine resulting in overcrowding and mismanagement. Many centers across India in months of April & May reported severe shortage of covid vaccines due to large crowds turning up for vaccination. In cities like Mumbai, New Delhi, Bengaluru many people even after waiting for hours did not receive their covid vaccine due to shortage.[198] Since July, vaccine supply has drastically increased thus India is vaccinating at a very fast pace.[199]

One study published on vaccine acceptance shows that 79.5% of people from Delhi want to take a COVID-19 vaccine.[200] In another study which was published from West Bengal, a state in Eastern India, has shown that 77.27% of people want to take the COVID-19 vaccine.[201] According to the finding from these two studies, it can be expected that over 75% of people want to get a COVID-19 vaccine.

Uttar Pradesh achieved 100% first dose saturation in COVID-19 vaccination, with over 26 crore doses administered, highest in India. The entire eligible population received the first dose by Monday evening. Nearly 70% of adult population fully vaccinated. Health teams praised for administering over 7 crore doses in January.[202]

Adverse events

Like many other vaccinations, COVID-19 vaccines also have a risk of causing side effects. According to India's Union Ministry of Health and Family Welfare, the most common side-effects include pain or swelling at the injection site, fever, irritability and headaches.[203] The UK Government also lists fatigue, nausea and joint pain as common side-effects of the Oxford vaccine (known as Covishield in India).[204] Medical experts maintain that vaccines used are safe and their benefits outweigh the risks. It is also important to note that adverse cases do not necessarily have a causal relationship with the vaccines.[205]

A total of 617 serious adverse events were reported until March 29. Of these, 180 cases resulted in death. The Immunisation Technical Support Unit at the federal health ministry examined 192,000 case reports, including 12,400 deaths. In more than half of the examined cases of death, the cause of death was found to be acute coronary syndrome. However, the documentation had been completed for only 3,500 cases.[206]

By 7 June, 26,000 adverse events had been reported following immunisation. Of this, 24,901 were minor, 412 were significant and 887 were serious. 488 deaths were also reported, including 301 men and 178 women (details of 9 deaths were not available). Both vaccines had an adverse reaction rate of about 0.01% and a fatality rate of around 0.0001% - 24,703 events and 457 deaths from 210 million Covishield doses, 1,497 events and 20 deaths following 25 million Covaxin doses. Maharashtra reported the most adverse events (4,521), followed by Kerala (4,074), Karnataka (2,650) and West Bengal (1,456).[205][207]

On 15 June, the government published a review of case reports that had occurred between 5 February and 31 March 2021, focusing on 31 cases and one death from anaphylaxis that were believed to have been attributed to the vaccine, out of nearly 60 million doses administered in the time period. Only three of these cases, and the single death of a 68-year-old patient, were determined to be "vaccine-product related", with the remainder having been classified as coincidental, indeterminate, or unclassifiable. The report stated that "mere reporting of deaths and hospitalisations as serious adverse events does not automatically imply that the events were caused due to vaccines. Only properly conducted investigations and causality assessments can help in understanding if any causal relationship exists between the event and the vaccine."[208][209][210]

References

Footnote references

  1. ↑ All government run vaccination centers provide free of cost vaccines
  2. ↑ Vaccination Centres/facilities charge as per dose

Web References

  1. ↑ "Budget 2021: Two more coronavirus vaccines soon, reveals FM Nirmala Sitharaman". Businesstoday.in. Retrieved 13 March 2021.
  2. ↑ "Vaccination state wise". Ministry of Health and Family Welfare. Retrieved 4 March 2023. (NB: The data on this site change daily)
  3. ↑ "Vaccination Statistics". vaccinate-india.in. Retrieved 2 December 2022.
  4. ↑ "Covid-19 Vaccination in India". Cowin.
  5. 1 2 3 4 5 "Covid-19 Vaccination in India". 4 March 2023.
  6. ↑ "Serum Institute gets DCGI's nod to manufacture Covid vaccine Sputnik V in India". mint. 4 June 2021.
  7. ↑ rdif.ru: press release
  8. ↑ Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C (23 June 2022). "Global impact of the first year of COVID-19 vaccination: a mathematical modelling study". The Lancet Infectious Diseases. 22 (9): 1293–1302. doi:10.1016/s1473-3099(22)00320-6. ISSN 1473-3099. PMC 9225255. PMID 35753318.
  9. ↑ "COVID-19 vaccines saved nearly 20 million lives in a year, study says". CBS News. 24 June 2022. Retrieved 27 June 2022.
  10. 1 2 3 4 "CoWIN Dashboard". 4 March 2023.
  11. ↑ "Our World in Data - Covid-19 Vaccination". GitHub. 4 March 2023.
  12. ↑ "CoWIN dashboard".
  13. ↑ "CoWIN".
  14. ↑ "Expect Covid-19 vaccine by early next year, will take first shot if any trust deficit: Vardhan". The Times of India. 13 September 2020. Retrieved 13 September 2020.
  15. ↑ Kaul, Rhythma (21 October 2020). "30 Million Frontline Workers To Get Covid-19 Vaccine In Phase 1". Hindustan Times. New Delhi. Retrieved 21 October 2020.
  16. ↑ "Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca". BBC News. 3 January 2021. Retrieved 22 April 2021.
  17. ↑ Beaumont, Peter (24 March 2021). "Delhi reportedly halts AstraZeneca Covid vaccine exports as cases soar". The Guardian. Archived from the original on 24 March 2021. Retrieved 22 April 2021.
  18. ↑ "Why is the EU unhappy with AstraZeneca?". BBC News. 6 April 2021. Retrieved 22 April 2021.
  19. ↑ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021.
  20. ↑ Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai.
  21. ↑ Perappadan, Bindu Shajan (16 January 2020). "Covaxin recipients asked to sign consent form on 'clinical trial mode'". The Hindu. New Delhi.
  22. ↑ Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai.
  23. 1 2 "World's largest vaccination programme begins in India on January 16". The Hindu. 15 January 2021. Retrieved 16 January 2021.
  24. ↑ Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai. Retrieved 16 January 2020.
  25. ↑ "No case of post-vaccination hospitalisation reported so far: Health Ministry". The Hindu. New Delhi. 16 January 2020. Retrieved 16 January 2020.
  26. ↑ "Over six lakh vaccinated so far". The Hindu. New Delhi. 19 January 2020. Retrieved 19 January 2020.
  27. ↑ "കോവിഡ് വാക്‌സിനേഷന്‍: പാര്‍ശ്വഫലമുണ്ടായത്‌ 0.18% പേരില്‍, ആശുപത്രിയില്‍ പ്രവേശിപ്പിച്ചത് 0.002% പേരെ". Mathrubhumi. New Delhi. 19 January 2020. Retrieved 19 January 2020.
  28. ↑ Ellis-Peterson, Hannah; Dhillon, Amrit (20 January 2020). "Indian hesitancy sets back world's biggest Covid vaccination drive". The Guardian. New Delhi. Retrieved 20 January 2020.
  29. ↑ Allana, Alia (15 March 2021). "Opinion | How Do You Vaccinate 1.3 Billion People?". The New York Times. ISSN 0362-4331. Retrieved 15 March 2021.
  30. ↑ "Coronavirus Registration for next phase of vaccination on Co-WIN 2.0 portal to open on March 1". The Hindu. 28 February 2021.
  31. ↑ "Citizen Registration and Appointment for Vaccination" (PDF). mohfw.gov.in. Archived from the original (PDF) on 19 June 2022. Retrieved 28 February 2021.
  32. ↑ "All above 60 years of age, 45-plus with comorbidities can get COVID-19 vaccine from March 1". The Economic Times. Retrieved 27 April 2021.
  33. ↑ "Covid-19 vaccination: How is India's inoculation drive going". BBC News. 20 April 2021. Retrieved 22 April 2021.
  34. ↑ "India reports new record of 103,558 daily Covid cases, as second wave and new lockdowns hit". CNN. 5 April 2021. Archived from the original on 5 April 2021. Retrieved 22 April 2021.
  35. ↑ Yeung, Jessie; Sud, Vedika (21 April 2021). "India's second Covid wave hits like a 'tsunami' as hospitals buckle under weight". CNN. Archived from the original on 21 April 2021. Retrieved 21 April 2021.
  36. 1 2 India's vaccine shortage will last months, biggest manufacturer warns, Financial Times, 3 May 2021.
  37. ↑ PTI (28 December 2020). "Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute". The Hindu.
  38. ↑ India is the home of the world's biggest producer of Covid vaccines. But it's facing a major internal shortage, CNBC, 5 May 2021.
  39. ↑ Leo, Leroy (11 March 2021). "DCGI removes Covaxin out of 'clinical trial mode'". mint. Retrieved 13 May 2021.
  40. ↑ "CoWin Upgrade, 50 lakh Daily Target: What to Expect As India Vaccinates Citizens Above 45". www.news18.com. 3 April 2021. Retrieved 27 April 2021.
  41. ↑ "PM Modi calls for 'Vaccine Utsav' from April 11–14; Aghadi split over vaccine stock; more". India Today. Retrieved 27 April 2021.
  42. ↑ "Tika Utsav: India to inoculate citizens on day 2 of 'vaccination festival' today". Hindustan Times. 12 April 2021. Retrieved 27 April 2021.
  43. ↑ "Tika Utsav: India's COVID-19 vaccination coverage exceeds 11 crore mark". The Economic Times. Retrieved 27 April 2021.
  44. 1 2 "Experts clear Russia's Sputnik Covid-19 vaccine for use in India". Hindustan Times. 12 April 2021. Retrieved 15 April 2021.
  45. ↑ "EXCLUSIVE India to get Russia's Sputnik V vaccine only by end-May". reuters. 26 April 2021. Retrieved 26 April 2021.
  46. ↑ "India announces next phase of Covid-19 vaccination, all above 18 yrs eligible". mint. 19 April 2021. Retrieved 28 May 2021.
  47. ↑ Koshy, Jacob. "Vaccines for all above 18 from May 1; States can buy directly". The Hindu. Retrieved 25 April 2021.
  48. ↑ "COVID-19 vaccine for all above age of 18 years from May 1; states can buy vaccines directly from manufacturers". Times Now News. 19 April 2021. Retrieved 20 April 2021.
  49. ↑ "Around 1.33 Crore Apply For Covid Vaccination: 10 Points". NDTV.com. Retrieved 1 May 2021.
  50. ↑ Yeung, Jessie; Suri, Manveena (May 2021). "Every adult in India is now eligible for Covid vaccine shots, but some states say they have none to offer". CNN. Retrieved 1 May 2021.
  51. ↑ "Watch: Russia's Sputnik V, 3rd Vaccine For India, Arrives In Hyderabad", NDTV, 1 May 201
  52. ↑ Kumar, N. Ravi (1 May 2021), "1.5 lakh doses of Sputnik V land in India", The Hindu
  53. ↑ Kumar, N. Ravi (14 May 2021). "Sputnik roll out begins, to cost ₹995 per dose". The Hindu. ISSN 0971-751X. Retrieved 15 May 2021.
  54. ↑ "Sputnik V Covid-19 vaccine production in India to start in August". The Times of India. New Delhi. 22 May 2021. Retrieved 25 May 2021.
  55. ↑ Bharadwaj, Swati. "Sputnik V manufacturing in India to begin after EUA nod". The Times of India. Archived from the original on 9 April 2021. Retrieved 28 May 2021.
  56. 1 2 "Sputnik launched in Hyderabad at ₹995 a dose". Hindustan Times. 15 May 2021. Retrieved 28 May 2021.
  57. ↑ "DCGI approves Covaxin clinical trials for children aged 2-18 years". DNA India. 13 May 2021. Retrieved 13 May 2021.
  58. ↑ Dey, Sushmi (14 May 2021). "Government vows vaccine push, says will get 217 crore shots from August to December". Times of India. Archived from the original on 16 May 2021. Retrieved 15 May 2021.
  59. ↑ Sensharma, Aalok (14 May 2021). "From Intranasal to Covovax, India pins hopes on 5 more COVID-19 vaccines as 2nd wave wreaks havoc". Jagran. New Delhi. Archived from the original on 16 May 2021. Retrieved 16 May 2021.
  60. ↑ "200 million vaccine doses administered in India". Hindustan Times. 26 May 2021. Retrieved 26 May 2021.
  61. 1 2 "Health ministry buys 300 mn doses of Biological-E's Covid vaccine in advance". Hindustan Times. 3 June 2021. Retrieved 4 June 2021.
  62. ↑ "No Question Of Anyone Being Left Out Of Covid Vaccination Due To Digital Divide, Centre Tells Court". NDTV. Press Trust of India. 27 June 2021. Retrieved 29 June 2021.
  63. ↑ "Supreme Court asks govt for a vaccine roadmap, calls policy for 18-44 to pay 'arbitrary, irrational'". The Indian Express. 3 June 2021. Retrieved 25 June 2021.
  64. ↑ "PVT hospitals can charge maximum of ₹150 as service fee for vaccination: PM". 7 June 2021.
  65. ↑ "It's centralised procurement of vaccines again, says PM Modi". The Hindu. 7 June 2021. Retrieved 7 June 2021.
  66. ↑ "Covid vaccination in India: Record 69 lakh Covid vaccine doses administered on day one of revised guidelines". The Times of India. 21 June 2021. Archived from the original on 21 June 2021. Retrieved 25 June 2021.
  67. ↑ "Day 1 of India's new COVID-19 vaccine policy: Record 82.7L doses administered, 'numbers gladdening', tweets PM". Firstpost. 22 June 2021. Retrieved 25 June 2021.
  68. ↑ "How MP Bested Other States in Vaccination: Over 8,000 Centres, Monitoring By CM". www.news18.com. 21 June 2021. Retrieved 25 June 2021.
  69. ↑ Sharma, Supriya (22 June 2021). "How India created a 'world record' for highest number of vaccinations in a single day". Scroll.in. Retrieved 25 June 2021.
  70. ↑ Sharma, Supriya (24 June 2021). "How India engineered its single-day Covid-19 vaccination "record"". Quartz. Retrieved 25 June 2021.
  71. ↑ ""Sprinting Ahead": BJP Chief On P Chidambaram's Vaccine Record Criticism". NDTV.com. Retrieved 25 June 2021.
  72. ↑ "After 'Record' High on Monday, Vaccine Numbers Drastically Drop in Some BJP-Ruled States". The Wire. 23 June 2021. Archived from the original on 23 June 2021. Retrieved 24 June 2021.
  73. ↑ "India's cumulative Covid-19 vaccination coverage crosses 30 crore". The Times of India. 23 June 2021. Retrieved 25 June 2021.
  74. ↑ "'Remarkable Result': India Zooms Past US in Number of Vaccine Doses Given, Time Taken Lesser by Month". 28 June 2021.
  75. 1 2 "India expands Covid vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon". The Times of India. 29 June 2021. Archived from the original on 29 June 2021. Retrieved 29 June 2021.
  76. ↑ "Cipla gets nod to import Moderna's vaccine for emergency use in India: Report". mint. 29 June 2021. Retrieved 29 June 2021.
  77. ↑ "In 6 months since launch of drive: Vaccine coverage crosses 50 cr doses". INDIAN EXPRESS. 7 August 2021.
  78. ↑ "India gets fifth Covid vaccine as Johnson & Johnson's single-shot vaccine gets nod". THE NEW INDIAN EXPRESS. 7 August 2021. Retrieved 7 August 2021.
  79. ↑ "At 88 lakh doses, India achieves highest single-day vaccination record". India TV.
  80. ↑ "India witnesses highest-ever single-day vaccination of 88.13 doses". The Times of India.
  81. ↑ "India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters.
  82. ↑ "India approves first Covid vaccine for children above 12 – 5 things to know". Livemint.
  83. ↑ "3-dose Zydus vaccine to be included in Covid vaccination programme: Govt". Business Standard India. Press Trust of India. 30 September 2021. Retrieved 30 September 2021.
  84. ↑ "Now foreigners can also get Covid-19 vaccine in India: Health ministry". 10 August 2021.
  85. ↑ Sushmi Dey (26 August 2021). "Half of India's adults have now got at least one dose of vaccine". The Times of India.
  86. ↑ "India administers over 1 cr COVID vaccines in single day, Uttar Pradesh tops chart; PM hails 'momentous feat'". Times Now News.
  87. ↑ "Himachal administers first dose of Covid vaccine to 100% of its population". Himdustan Times.
  88. ↑ "India administers over 1.2 cr Covid vaccine doses, sets new single-day record". Livemint.
  89. ↑ "Covid-19 vaccine: City Beautiful not on Centre's list of 100% first dose coverage".
  90. ↑ "Goa achieved 100 pc first dose COVID vaccination, target set to complete 2nd dose by Oct 31: CM Sawant". ANI.
  91. ↑ "India administers over 74 crore Covid vaccines; all adults in 6 states, UTs got 1st dose". 12 September 2021.
  92. ↑ "India sets record with 2.5 crore COVID-19 jabs in one day". 17 September 2021. Retrieved 18 September 2021.
  93. ↑ "A Madhya Pradesh Twist To Record Vaccination Numbers On PM Modi Birthday". NDTV.com. Retrieved 23 September 2021.
  94. ↑ "Shocking! Woman vaccinated four months after her death due to Covid complications in MP". The New Indian Express. Retrieved 23 September 2021.
  95. ↑ "India administers 1 crore vaccine doses for 5th time, vaccination coverage crosses 86 crore".
  96. ↑ "Over 90 crore Covid vaccine doses administered in India: Health minister". The Times of India. 2 October 2021. Retrieved 2 October 2021.
  97. ↑ "Govt allows Serum Institute to enrol 7-11 year olds in Covid-19 vaccine trial". mint. 28 September 2021. Retrieved 28 September 2021.
  98. ↑ Mordani, Sneha (29 September 2021). "Do Indians need booster dose of Covid-19 vaccines? Experts answer". India Today. Retrieved 15 August 2022.
  99. ↑ "India crosses 100-crore Covid vaccination mark, PM Modi says country 'scripts history'". ThePrint. 21 October 2021. Retrieved 22 October 2021.
  100. ↑ "Boosters For 60+, Frontline Staff; Vaccines For 15-18, Says PM: 10 Points". NDTV.com. Retrieved 15 August 2022.
  101. ↑ "Covid Vaccination for Children in India: Children between 15-18 years can register on CoWin from Jan 1, on-site from Jan 3 | India News – Times of India". The Times of India. TNN. 28 December 2021. Retrieved 15 August 2022.
  102. ↑ "Covid vaccination for 12-14 age group from March 16; comorbidity clause for 60+ removed". Times of India. 14 March 2022. Retrieved 11 July 2022.
  103. ↑ "Precautionary Dose for eligible population from April 10". Press Information Bureau. 8 April 2022. Retrieved 11 July 2022.
  104. ↑ Rajagopal, Krishnadas (2 May 2022). "COVID-19: Supreme Court upholds individual's right against forcible vaccination". The Hindu. ISSN 0971-751X. Retrieved 15 August 2022.
  105. ↑ Ray, Meenakshi (6 May 2020). "30 Covid-19 vaccines in different stages of development: Scientists to PM Modi". Hindustan Times. Retrieved 10 May 2020.
  106. ↑ Yeung, Jessie; Mitra, Esha (18 April 2021). "The world's biggest vaccine producer is running out of Covid-19 vaccines". CNN. Archived from the original on 18 April 2021. Retrieved 18 April 2021.
  107. ↑ Khelkar, Pankaj P. (19 February 2020). "Indian company first to test coronavirus vaccine on animals, human trials expected in 6 months". India Today. Retrieved 13 April 2020.
  108. ↑ "Coronavirus vaccine within a year but it won't be 100% effective". The Economic Times. 21 March 2020. Retrieved 22 March 2020.
  109. ↑ "Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India". Daily News & Analysis. 3 August 2020. Retrieved 4 August 2020.
  110. ↑ "Serum Institute to produce up to 100 million Covid-19 vaccine doses for India, other countries". The Times of India. 7 August 2020. Retrieved 10 August 2020.
  111. 1 2 Fletcher, Martin. "Adar Poonawalla: 'Aggression over Covid vaccines is overwhelming . . . Everyone expects to get theirs first'". The Times. ISSN 0140-0460. Retrieved 28 May 2021.
  112. ↑ Schmall, Emily; Yasir, Sameer (3 January 2021). "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other". The New York Times. Archived from the original on 28 December 2021.
  113. ↑ Adar Poonawalla: 'Aggression over jabs is overwhelming Everyone expects to get theirs first, The Times, 1 May 2021. ProQuest 2520110820
  114. ↑ "Hyderabad-based biotech firm working on nasal vaccine for Covid-19". India Today. 3 April 2020. Retrieved 6 April 2020.
  115. ↑ Chakrabarti, Angana (10 May 2020). "India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech". The Print. Retrieved 11 May 2020.
  116. ↑ "India's First COVID-19 Vaccine Candidate Approved for Human Trials". The New York Times. 29 June 2020.
  117. ↑ "India's coronavirus vaccine candidate COVAXIN showed positive result in animals: Bharat Biotech". Daily News & Analysis. 12 September 2020. Retrieved 13 September 2020.
  118. ↑ Suri M, Hollingsworth J (3 July 2021). "India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says". CNN. Retrieved 3 July 2021.
  119. ↑ Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al. (2 July 2021). "Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial". medRxiv 10.1101/2021.06.30.21259439v1.
  120. ↑ Bharadwaj, Swati (20 April 2021). "Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum". The Times of India. Archived from the original on 20 April 2021. Retrieved 24 May 2021.
  121. ↑ Jayakumar, PB (5 April 2020). "Zydus Cadila, Serum Institute too in the hunt for coronavirus vaccine". India Today. Retrieved 6 April 2020.
  122. ↑ "The experiment of coronavirus vaccine on animals started in India, hopefully desired results will come in 4–6 months". Inventia. 8 April 2020. Retrieved 13 April 2020.
  123. ↑ "Coronavirus vaccine update: India's second COVID-19 vaccine candidate 'ZyCoV-D' to start human trials; here is all you need to know". The Times of India. 15 July 2020. Retrieved 16 July 2020.
  124. ↑ "DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials". Press Information Bureau, Government of India. 3 January 2021. Retrieved 24 May 2021.
  125. ↑ "Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects". ctri.nic.in. Clinical Trials Registry – India. Archived from the original on 20 January 2021. Retrieved 10 April 2021.
  126. ↑ "Cadila Healthcare starts production of Covid vaccine candidat". livemint. 26 April 2021. Retrieved 26 April 2021.
  127. ↑ "Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world's first Plasmid DNA vaccine for COVID-19" (PDF). Cadila Healthcare (Press release). 1 July 2021. Archived from the original (PDF) on 2 July 2021. Retrieved 1 July 2021.
  128. ↑ "Zydus Cadila jab shows 66.6% efficacy, seeks regulatory nod". livemint. 2 July 2021. Retrieved 2 July 2021.
  129. ↑ Saxena, Sparshita, ed. (16 September 2020). "Russia's sovereign wealth fund partners with Dr Reddy's for trials and distribution of Sputnik V vaccine in India". Hindustan Times. Retrieved 24 May 2021.
  130. ↑ "Russia inks pact to test, supply Sputnik V vaccine to India". The Hindu. 16 September 2020.
  131. ↑ "On Sputnik V For India, Price Issues – AstraZeneca Price Too Low, Says Maker". NDTV.com. Retrieved 28 May 2021.
  132. ↑ "Biological E gets nod to start Phase III trials of COVID-19 vaccine". The Hindu. 24 April 2021.
  133. ↑ "Foreign COVID-19 vaccines exempted from local trials, batch testing". in.news.yahoo.com. Retrieved 29 June 2021.
  134. ↑ Sharma, Milan. "Talks with vaccine makers Moderna, Pfizer stuck on indemnity clause: Sources". India Today. Archived from the original on 13 July 2021. Retrieved 20 July 2021.
  135. ↑ "Terms of Indemnity for Foreign Makers Hold Up Covid Vaccine Donations from US as Neighbours Get Share". News18. 13 July 2021. Retrieved 20 July 2021.
  136. ↑ Arora, Neha; Das, Krishna N.; Ahmed, Aftab (21 September 2021). "India govt won't buy Pfizer, Moderna vaccines amid local output -sources". Reuters.
  137. 1 2 3 4 "India to make available 8 million doses of J&J Covid vaccine: PM Modi at Quad Summit".
  138. 1 2 "Sputnik Light: DCGI nod to emergency use of single-dose Covid vaccine". Livemint. 2 February 2022.
  139. ↑ Mandal, Sandip; Arinaminpathy, Nimalan; Bhargava, Balram; Panda, Samiran (1 July 2021). "Responsive and agile vaccination strategies against COVID-19 in India". The Lancet Global Health. 9 (9): e1197–e1200. doi:10.1016/S2214-109X(21)00284-9. ISSN 2214-109X. PMC 8248922. PMID 34217378.
  140. ↑ Foy, Brody H.; Wahl, Brian; Mehta, Kayur; Shet, Anita; Menon, Gautam I.; Britto, Carl (1 February 2021). "Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study". International Journal of Infectious Diseases. 103: 431–438. doi:10.1016/j.ijid.2020.12.075. ISSN 1201-9712. PMC 7834611. PMID 33388436.
  141. ↑ Gurnani, Vandana; Haldar, Pradeep; Aggarwal, Mahesh Kumar; Das, Manoja Kumar; Chauhan, Ashish; Murray, John; Arora, Narendra Kumar; Jhalani, Manoj; Sudan, Preeti (7 December 2018). "Improving vaccination coverage in India: lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy". BMJ. 363: k4782. doi:10.1136/bmj.k4782. ISSN 0959-8138. PMC 6282735. PMID 30530467.
  142. ↑ Hunziker, Patrick (24 July 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine. 4 (3): 805–820. doi:10.33218/001c.26101.
  143. ↑ Sharma, Manavi Kapur, Niharika (8 May 2021). "Adar Poonawalla has confusing—and often contradictory—reasons for India's vaccine shortage". Quartz. Retrieved 10 May 2021.{{cite web}}: CS1 maint: multiple names: authors list (link)
  144. 1 2 3 4 5 6 "Over 2 billion vaccines to be available by Dec: Centre". HindustanTimes. 14 May 2021. Retrieved 29 July 2021.
  145. ↑ "Centre pins hopes on 5 Covid vaccines apart from Covishield, Covaxin, Sputnik". Hindustan Times. 14 May 2021. Retrieved 3 June 2021.
  146. ↑ "Oxford Covid vaccine approved, three more awaiting nod, confirms Javadekar". The Times of India. 2 January 2021.
  147. 1 2 Perappadan, Bindu Shajan (9 January 2021). "Coronavirus | First phase of vaccination to start on January 16". The Hindu – via www.thehindu.com.
  148. ↑ "Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum". The Hindu. 20 April 2021. ISSN 0971-751X. Retrieved 10 May 2021.
  149. ↑ "India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"". NDTV.com.
  150. ↑ "Covid 19: India gets third vaccine, Sputnik V". Financial Express. 15 May 2021.
  151. ↑ "Dr Reddy's administers first dose of Sputnik V vaccine as part of pilot project". mint. 14 May 2021.
  152. ↑ "COVID-19 Vaccines: Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021". Money Control. 7 May 2021. Retrieved 29 July 2021.
  153. ↑ Bharadwaj, Swati (3 June 2021). "Bio E to get Rs 1,500 crore advance from government to reserve 30 crore doses of Corbevax". The Times of India. Archived from the original on 3 June 2021. Retrieved 3 June 2021.
  154. 1 2 Achom, Debasish (28 December 2021). "India Clears 2 New Vaccines And Merck's Covid Pill". NDTV.com.
  155. 1 2 Sushmi Dey (26 March 2022). "Ahead of new school session, 1 crore kids aged 12-14 get 1st Covid shot | India News – Times of India". The Times of India. Retrieved 9 May 2022.
  156. ↑ "Government nod for Cipla to import Moderna's COVID-19 vaccine". The Hindu. 29 June 2021.
  157. ↑ Kaul, Rhythma (29 June 2021). "Moderna's Covid vaccine approved for use in India". Hindustan Times.
  158. ↑ "India to not buy Pfizer, Moderna Covid-19 vaccines as local production jumps: Report". 21 September 2021.
  159. ↑ "Johnson & Johnson's Single-Dose Covid Vaccine Approved In India". NDTV.com. Retrieved 7 August 2021.
  160. ↑ "Cadila Healthcare starts production of Covid vaccine candidate". mint. 24 April 2021. Retrieved 27 April 2021.
  161. ↑ Umarji, Vinay (8 November 2021). "Cadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D". Business Standard India. Retrieved 9 May 2022.
  162. ↑ "India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters. 20 August 2021.
  163. ↑ "Bharat Biotech's intranasal vaccine for COVID-19: Everything we know so far about BBV154". Tech2. Firstpost. 12 March 2021.
  164. ↑ Prabhu, Sunil. "Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod". NDTV.com. Retrieved 13 August 2021.
  165. ↑ Raghavan P (15 December 2020). "Pune-based Gennova to begin human trials of its Covid vaccine 'soon'". The Indian Express.
  166. ↑ "Vaccine Maitri: Consignment of covid vaccines airlifted for Guyana, Jamaica". mint. 5 March 2021. Retrieved 27 April 2021.
  167. ↑ "Vaccine Maitri: A Sanjeevini for the world". The Hindu Business Line. 4 March 2021. Retrieved 10 March 2021.
  168. 1 2 3 "Ministry of External Affairs – Government of India". Ministry of External Affairs – Government of India.
  169. ↑ "Coronavirus: India temporarily halts Oxford-AstraZeneca vaccine exports". BBC News. 24 March 2021. Retrieved 19 May 2021.
  170. ↑ "Covid vaccine: India to resume vaccine exports from October". BBC News. 21 September 2021. Retrieved 23 September 2021.
  171. ↑ "India Pledges Support To UN To Ensure Syria Gets Covid Vaccines". NDTV.com. Retrieved 23 March 2021.
  172. ↑ India's 'gift' to UN peacekeepers: 200,000 Covid vaccine doses, Mint, 26 March 2021.
  173. ↑ "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 2 January 2021.
  174. ↑ "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 2 January 2021.
  175. ↑ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 2 January 2021.
  176. 1 2 Bhattacherjee, Kallol (20 January 2021). "Coronavirus | India begins COVID-19 vaccine shipment for six countries-IN". The Hindu. ISSN 0971-751X. Retrieved 15 March 2021.
  177. ↑ "Covid-19: Canada receives 500,000 doses of Covishield vaccine made in India". Hindustan Times. 3 March 2021. Retrieved 15 March 2021.
  178. ↑ Acharya, Bhargav (3 March 2021). "UK to receive 10 million AstraZeneca COVID-19 vaccine doses from India's Serum Institute". Reuters. Retrieved 15 March 2021.
  179. ↑ Das, Krishna N. (26 January 2021). "Exclusive: Saudi Arabia to get three million AstraZeneca shots in about a week from India". Reuters. Retrieved 15 March 2021.
  180. ↑ "WHO-led Covax vaccine scheme agrees to new supply deal with Serum Institute of India". The Indian Express. 3 February 2021. Retrieved 15 March 2021.
  181. ↑ Mazumdar, Tulip (17 May 2021). "India's Covid crisis hits Covax vaccine-sharing scheme". BBC News. Retrieved 19 May 2021.
  182. ↑ Findlay, Stephanie; Pilling, David (18 May 2021). "Indian vaccine maker extends freeze on export of Covid jabs". Financial Times. Retrieved 19 May 2021.
  183. ↑ "Covid-19: Has India's deadly second wave peaked?". BBC News. 26 May 2021. Retrieved 23 July 2021.
  184. ↑ "Why Covid-19 Vaccination in Poorer Nations Has Slowed, Posing Global Risks". The Wall Street Journal. Retrieved 24 April 2021.
  185. ↑ "India 'at forefront' in fighting COVID-19; 'stands out' in vaccine policy, says IMF's Gita Gopinath". Business Today. 9 March 2021. Retrieved 12 March 2021.
  186. 1 2 "African, Caribbean nations support India at WTO on COVID-19 vaccine supplies". The Hindu. 4 March 2021. Retrieved 10 March 2021.
  187. ↑ "Nepal PM thanks India for coronavirus vaccines". WION. Retrieved 16 July 2021.
  188. ↑ "India's 'Vaccine Maitri' initiative earns praise at WTO". The Hindu Business Line. 3 March 2021. Retrieved 10 March 2021.
  189. ↑ Barbados Prime Minister Thanks PM Modi For Supply Of Covid Vaccines, NDTV, 4 March 2021.
  190. ↑ "Vaccine Maitri: Tajikistan, Belize, Jamaica Receive 'Made in India' COVID-19 Vaccines". The Eurasian Times. 9 March 2021. Retrieved 11 March 2021.
  191. ↑ "India supplies 5 lakh more Covid vaccine Covaxin doses to Afghanistan". 3 January 2022.
  192. ↑ "Top Cambodian leaders receive 1st shot of India-made Covid-19 vaccine". Business Standard India. Business Standard. 11 March 2021. Retrieved 11 March 2021.
  193. ↑ "Nepal PM KP Sharma Oli receives shot of India-made Covishield Covid vaccine". India Today. Retrieved 11 March 2021.
  194. ↑ "Home | Ministry of Health and Family Welfare Cumulative | Coverage Report of COVID-19 Vaccination | GOI" (PDF). www.mohfw.gov.in. Retrieved 4 March 2023.
  195. ↑ "Covid-19 Vaccination in India". 4 March 2023.
  196. ↑ springer.com/article/10.1007/s10654-021-00728-6#data-availability
  197. ↑ "Driven by rural India boost, daily vaccination gathers pace in Aug". The Times of India. 9 August 2021.
  198. ↑ "Vaccine shortage: 40 centres to remain shut in Mumbai on April 29". 28 April 2021.
  199. ↑ "India's Covid-19 Vaccination Drive Gathers Speed as More Jabs Gain Approval". Forbes.
  200. ↑ Islam, F., Agarwalla, R., Panda, M., Alvi, Y., Singh, V., Debroy, A., Ray, A., Vadnerkar, A. and Uttekar, S., 2021. Assessment of the knowledge, preferences and concern regarding the prospective COVID-19 vaccine among adults residing in New Delhi, India-A cross-sectional study. medRxiv.
  201. ↑ Gautam, A., Dhara, B., Mukherjee, D., Mukhopadhyay, D., Roy, S., Ganguly, S.S., Chowdhury, A.D., Goswami, S., Dey, S., Basu, S. and Chatterjee, S., 2020. A Digital Survey on the Acceptance and Affordability of COVID 19 Vaccine among the People of West Bengal, India-A Survey Based Study. medRxiv.
  202. ↑ "UP vaccination update". The Times of India. 31 January 2022.
  203. ↑ "Common Side Effects (AEFI)". Min. Health & Family Welfare, GoI. Retrieved 21 June 2021.
  204. ↑ "Information for UK recipients" (PDF). Medicines and Healthcare Products Regulatory Agency, UK. Retrieved 21 June 2021.
  205. 1 2 "26k Adverse Events, 488 Deaths Reported in India During Covid Vaccination Drive: Data". News 18. 14 June 2021. Retrieved 20 June 2021.
  206. ↑ "61700 Serious Adverse Events After Vaccination Reported In India Until March 29". The Wire. Bengaluru. 9 April 2021. Retrieved 10 April 2021.
  207. ↑ "കോവിഡ് വാക്സിനേഷൻ: രാജ്യത്ത് പ്രതികൂല സംഭവങ്ങൾ 0.01%; മരണം 10 ലക്ഷത്തിൽ രണ്ട്". Mathrubhumi. New Delhi. 14 June 2021. Retrieved 15 June 2021.
  208. ↑ Mordani, Sneha (15 June 2021). "Govt confirms first death after Covid vaccination in India". India Today. Retrieved 15 June 2021.
  209. ↑ "Govt's review of side effects confirms 1 death after vaccine dose". Hindustan Times. 15 June 2021. Retrieved 15 June 2021.
  210. ↑ "Govt confirms first death due to COVID-19 vaccination". www.businesstoday.in. 15 June 2021. Retrieved 15 June 2021.

Notes

  1. ↑ Moderna, Johnson & Johnson and Zydus Cadila are not yet under distribution
  2. ↑ Zydus Cadila is the only vaccine to been approved for children above 12 years
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.